Our secondary objective was to investigate the membranous NECTIN‐4 expression across various stages of PCa, guided by insights from mUC, emphasizing the importance of considering diverse expression patterns before implementing EV in clinical contexts.13 This evidence concerns the gene NECTIN4 and posterior cortical atrophy.